First National Trust Co. boosted its position in Express Scripts Holding Co. (NASDAQ:ESRX) by 15.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,703 shares of the company’s stock after buying an additional 636 shares during the period. First National Trust Co.’s holdings in Express Scripts Holding were worth $356,000 at the end of the most recent reporting period.
Other institutional investors have also recently modified their holdings of the company. BloombergSen Inc. increased its position in shares of Express Scripts Holding by 5.4% in the second quarter. BloombergSen Inc. now owns 1,396,497 shares of the company’s stock worth $105,854,000 after buying an additional 71,949 shares during the period. Financial Enhancement Group LLC increased its stake in Express Scripts Holding by 2.6% in the second quarter. Financial Enhancement Group LLC now owns 74,658 shares of the company’s stock worth $5,659,000 after buying an additional 1,901 shares during the period. Clean Yield Group increased its stake in Express Scripts Holding by 8.4% in the second quarter. Clean Yield Group now owns 6,484 shares of the company’s stock worth $491,000 after buying an additional 500 shares during the period. Agran Libbie bought a new stake in Express Scripts Holding during the second quarter worth about $205,000. Finally, VNBTrust National Association increased its stake in Express Scripts Holding by 22.7% in the second quarter. VNBTrust National Association now owns 50,865 shares of the company’s stock worth $3,855,000 after buying an additional 9,425 shares during the period. 88.52% of the stock is currently owned by institutional investors.
Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded up 0.01% during trading on Thursday, reaching $70.35. 2,771,710 shares of the company’s stock were exchanged. The company’s 50-day moving average is $71.94 and its 200 day moving average is $73.70. Express Scripts Holding Co. has a 52 week low of $65.55 and a 52 week high of $89.20. The stock has a market capitalization of $44.34 billion, a PE ratio of 17.38 and a beta of 1.16.
Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Monday, July 25th. The company reported $1.57 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.57. The company had revenue of $25.20 billion for the quarter, compared to analyst estimates of $25.42 billion. Express Scripts Holding had a net margin of 2.64% and a return on equity of 23.98%. The business’s quarterly revenue was down .9% on a year-over-year basis. During the same quarter last year, the firm posted $1.44 earnings per share. On average, analysts forecast that Express Scripts Holding Co. will post $6.36 earnings per share for the current year.
A number of research firms have recently issued reports on ESRX. Zacks Investment Research downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Tuesday, July 19th. Barclays PLC boosted their price target on shares of Express Scripts Holding from $85.00 to $87.00 and gave the company an “overweight” rating in a research note on Wednesday, July 27th. Jefferies Group reduced their price target on shares of Express Scripts Holding from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Tuesday, July 26th. Mizuho boosted their price target on shares of Express Scripts Holding from $77.00 to $82.00 and gave the company a “neutral” rating in a research note on Tuesday, August 2nd. Finally, Credit Suisse Group AG reissued a “buy” rating on shares of Express Scripts Holding in a research note on Monday, June 27th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $81.53.
In related news, VP Christopher A. Mcginnis sold 1,785 shares of Express Scripts Holding stock in a transaction on Monday, September 12th. The shares were sold at an average price of $70.77, for a total value of $126,324.45. Following the completion of the sale, the vice president now owns 4,955 shares in the company, valued at $350,665.35. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of Express Scripts Holding stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total transaction of $847,334.40. Following the completion of the sale, the director now owns 14,918 shares of the company’s stock, valued at approximately $1,050,227.20. The disclosure for this sale can be found here. Insiders own 0.54% of the company’s stock.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co. (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.